SCHEMBL216981

SCHEMBL216981

Cc1cccc2c1[CH]c1ccccc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.39
TSHR P16473 2/20 0.39
CYP3A4 P08684 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP2A6 P11509 2/20 0.35
CYP1A2 P05177 1/20 0.35
ALDH1A1 P00352 3/20 0.34
CD44 P16070 1/20 0.34
NPC1 O15118 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
MYC P01106 1/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA7 P43166 2/20 0.33
CA9 Q16790 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3064332 0.89 DCUN1D1 (0.40) ACHETSHRCYP3A4TDP1CYP2A6
SCHEMBL2052191 0.83 CYP2A6 (0.43) ACHETSHRTDP1CYP2A6CYP1A2
SCHEMBL218438 0.78 TSHR (0.34) ACHETSHRCYP3A4TDP1CYP2A6
SCHEMBL2969427 0.77 ADORA3 (0.39) ACHETSHRTDP1ALDH1A1NPC1
SCHEMBL1028158 0.76 ALDH1A1 (0.36) ACHETSHRCYP3A4TDP1CYP1A2
SCHEMBL2966499 0.75 DCUN1D1 (0.31) ALDH1A1NPC1RAB9ASMN1; SMN2DCUN1D1
SCHEMBL3192100 0.74 ALDH1A1 (0.48) ACHETSHRCYP3A4TDP1ALDH1A1
SCHEMBL1029178 0.74 IDO1 (0.32) TSHRCYP3A4CYP1A2LMNA
SCHEMBL2959272 0.74
SCHEMBL2974242 0.74 PTPRC (0.37) CYP3A4CYP2A6CYP1A2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 750 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117304207-A Compound containing phenoxazinooxazole structure and application thereof 烟台九目化学股份有限公司 2023-12-29 CN claimed
CN-117143058-A Triarylamine compound and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2023-12-01 CN claimed
WO-2023201590-A1 LIGHT-EMITTING MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE, LIGHT-EMITTING DEVICE, AND DISPLAY DEVICE 京东方科技集团股份有限公司 2023-10-26 WO claimed
CN-116730846-A Organic compound containing phenylfluorene and organic light-emitting device thereof 长春海谱润斯科技股份有限公司 2023-09-12 CN claimed
WO-2020253445-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 陕西莱特光电材料股份有限公司 2020-12-24 WO claimed
CN-111943902-A Triarylamine compound and organic light-emitting device thereof 长春海谱润斯科技有限公司 2020-11-17 CN claimed
CN-111892587-A Heterocyclic organic compound and organic light-emitting device thereof 长春海谱润斯科技有限公司 2020-11-06 CN claimed
US-10741769-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-08-11 US claimed
CN-110452200-A Heterocyclic compound and organic light emitting apparatus comprising the heterocyclic compound SAMSUNG DISPLAY CO LTD 2019-11-15 CN claimed
CN-109564213-A Detecting microbial wound infection 西诺福有限公司 2019-04-02 CN claimed
US-5733990-A Catalyst for producing polyolefin and process for producing polyolefin DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1998-03-31 US claimed
US-5677255-A COMPLEX OF GROUP 4A METAL ON ORGANOSILICON POLYMER DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-14 US claimed
US-5627247-A COMPOUNDS OF CYCLOPENTADIENE OR INDENE WITH FLUORENE AND GROUP IV METALS PHILLIPS PETROLEUM COMPANY (US) 1997-05-06 US claimed
EP-0750508-A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS BIOMERIEUX (FR) 1997-01-02 EP claimed
WO-1995024916-A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND IN VITRO DIAGNOSIS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1995-09-21 WO claimed
US-5393911-A Cyclopentadiene type compounds and method for making PHILLIPS PETROLEUM COMPANY (US) 1995-02-28 US claimed
US-5359102-A Having cyclopentadienyl, indenyl, dicyclopentadienyl, and or fluorenyl group or theier derivatives as a legand used together with cocatalyst aluminoxane MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1994-10-25 US claimed
EP-0572990-A2 Method for preparing ethylene copolymer MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-12-08 EP claimed
CN-1066440-A Cyclopeutadiene type compounds and preparation method thereof PHILLIPS PETROLEUM CO (US) 1992-11-25 CN claimed
EP-0512554-A2 Cyclopetadiene type compounds and method for making PHILLIPS PETROLEUM COMPANY (US) 1992-11-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10741769-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device NR2E3, NR0B1, NR2E1 ACHE 2801/4885TSHR 1117/4885CYP3A4 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.